Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-5869.82%Net Margin
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Net Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - Net % Historical data
| Date | Net Income Common Stock | Net Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -50.95M | -5869.82% | $ 868K |
| 3/31/2025 | $ -40.06M | -2163.17% | $ 1.85M |
| 12/31/2024 | $ -59.6M | -2630.14% | $ 2.27M |
| 9/30/2024 | $ -71M | -3119.33% | $ 2.28M |
| 6/30/2024 | $ -107.83M | -4487.39% | $ 2.4M |
| 3/31/2024 | $ -153.05M | -8715.72% | $ 1.76M |
| 12/31/2023 | $ -179.05M | -12974.86% | $ 1.38M |
| 9/30/2023 | $ -211.6M | -17037.44% | $ 1.24M |
| 6/30/2023 | $ -202.92M | -19549.52% | $ 1.04M |
| 3/31/2023 | $ -187.08M | -32199.48% | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) Net % stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average Net % has been -21083.44%.
- The median Net % for BIOXCEL THERAPEUTICS INC during this period was -10845.29%
- BIOXCEL THERAPEUTICS INC reached its highest Net % over the past 5 years at -2163.17%.
- The lowest Net % recorded by BIOXCEL THERAPEUTICS INC in the same timeframe -100052.55%
BIOXCEL THERAPEUTICS INC's Net % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
Definition of Net Margin
[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.Net Inc. Cmn. / Revenues
(=) Net % Net % for BIOXCEL THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -69.36M ] / Revenues [ $ 0 ]
(=) Net % [ 0% ] BTAI - Net Margin, Last 5 years
-100052.55%
Minimum
Sep 30, 2022
-2163.17%
Maximum
Mar 31, 2025
-21083.44%
Average
-10845.29%
Median
Net % Benchmark AnalysisMarket
The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.8% with a standard deviation of 19.81%.
The following table provides additional summary stats:
Net % in the Market:
| filtered constituents | 3.19K |
|---|---|
| min | -63.83% |
| max | 69.74% |
| average | 4.8% |
| median | 5.26% |
| std | 19.81% |